AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

North Atlantic Smaller Companies Invesment Trust PLC

Interim / Quarterly Report Jul 31, 2013

5189_ir_2013-07-31_a69d567c-ab5d-4ba3-b8c9-7a6e16fa17e2.pdf

Interim / Quarterly Report

Open in Viewer

Opens in native device viewer

North Atlantic Smaller Companies Investment Trust plc Half-Yearly Report for the six months ended 31 July 2013

objective of the company and financial highlights

The objective of the Company is to provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

31 July 31 January
2013 2013 %
(unaudited) (audited) Change
Net asset value per 5p Ordinary Share*:
Diluted
1,824p 1,677p 8.8
Mid-market price of the 5p Ordinary Shares 1,492.5p 1,316.0p 13.4
Discount to diluted net asset value* 18.2% 21.5%
Standard & Poor's 500 Composite Index** 1,108.5 944.8 17.3
Russell 2000 Index** 687.4 568.9 20.8
FTSE All-Share Index 3,509.9 3,287.4 6.8
US Dollar/Sterling exchange rate 1.5161 1.5855 (4.4)

* Including retained revenue for the period.

** Sterling adjusted.

The cover depicts a painting by the artist Nicholas Pocock entitled 'HMS Brunswick breaking the line at the battle of the "Glorious First of June" 1794.'

© National Maritime Museum, Greenwich, London.

The Company is a member of the Association of Investment Companies.

Registered in England and Wales number 1091347

chief executive's review

During the six month period under review, the diluted net asset
value of the Company rose 8.8%. This compares with a rise in the
sterling adjusted Standard & Poor's Composite Index of 17.3%.
Performance suffered due to the high level of cash in the portfolio
and the inevitable lag from the substantial unquoted investments.
Income for the period amounted to a loss of £44,000 (31 July 2012:
loss of £307,000). Consistent with past policy, the Directors do not
propose to pay a dividend (31 July 2012: nil).
The quoted portfolio has generally performed well with notable
successes including BBA, CVA Group and Gleeson. Bioquell and
Nationwide were broadly flat. Mecom was, however, disappointing and
fell significantly during the period although recent results were much
better than expected. Oryx International Growth Fund rose by 10%.
Unquoted assets currently account for approximately 37% of the assets
of the Fund. The principal event that occurred during the period was
the successful sale of Bionostics at a premium of about 25% in excess of
holding cost, and just under four times original cost.
Celsis also sold off another small subsidiary which has enabled the
Company to recoup 100% of its original investment. Recent trading
has been encouraging.
Sinav was successful in a lawsuit and the investment was written up
to reflect this favourable outcome.
Finally, Orthoproducts is in discussions to be sold which, if successful,
would result in a write up on this investment of approximately 25%
and a sale at approximately four times original cost.
Equity markets have performed strongly on the back of the prospect
of continuing low interest rates and modestly better than expected
economic growth in both the UK and the USA. This has made it
harder to find opportunities in publicly listed companies. The
Company now has substantial cash reserves and is well placed to take
advantage of new opportunities as they arise.

chief executive's review (continued)

Notwithstanding this, the Company's investments are for the most part performing strongly and it is expected that the Company will continue to prosper through the balance of the year.

C H B Mills Chief Executive

17 September 2013

top ten investments

as at 31 July 2013

Company Fair
value
£'000
% of equity
attributable
to equity
holders
of the
Company
US Treasury Bills US Treasury Stock 48,470 16.6
Gleeson (MJ) Group PLC UK Listed 29,750 10.2
Oryx International Growth Fund Limited*† UK Listed 27,715 9.5
Trident Private Equity Fund III LP UK Unquoted 21,044 7.2
Hampton Investment Properties Limited †† UK Unquoted 14,093 4.8
Celsis AG US Unquoted 12,864 4.4
Bioquell UK Listed 11,457 3.9
Guinness Peat Group** UK Listed 11,445 3.9
Assetco PLC UK Listed 8,663 3.0
Orthoproducts Limited UK Unquoted 8,250 2.8
193,751 66.3

* Incorporated in Guernsey

  • ** Incorporated in New Zealand
  • † Oryx is accounted for in the Group accounts as an Associate under the equity method of accounting. The valuation shown above is the Group's share of Oryx's net assets. All other investments are valued at fair value.

†† Hampton Investment Properties Limited is accounted for in the Group accounts as a Subsidiary.

interim management report

investment objective The objective of North Atlantic Smaller Companies Investment Trust
PLC ("the Company") is to provide capital appreciation through
investment in a portfolio of smaller companies principally based in
countries bordering the North Atlantic Ocean.
material events The Board do not consider that there were any material events
during the period ended 31 July 2013.
material transactions As referred to in the Chief Executive's review on page 1, the Company's
investment in Bionostics was sold during the period under review at
a premium of approximately 25% of holding cost and at four times
the original cost of the investment.
risk profile The principal risks and uncertainties for the remaining six months
of the year continue to be as described in the Annual Report for
the year ended 31 January 2013 on page 19 and pages 64 to 72. The
principal risks arising from the Company's financial instruments are
market price risk, including currency risk, liquidity risk and credit/
counterparty risk. The Directors review and agree policies with the
Joint Manager, Harwood Capital LLP, for managing these risks. The
policies have remained substantially unchanged in the six months
since the year end.
The Group does not have any significant exposure to credit risk
arising from any one individual party. Credit risk is spread across
a number of companies, each having an immaterial effect on the
Group's cash flows, should a default occur. The Group assesses the
credit worthiness of its debtors from time to time to ensure that they
are neither past due or impaired.
To support its investment in unquoted companies, the Group may
periodically agree to guarantee all or part of the borrowings of investee
companies. Provision is made for any costs that may be incurred when
the Directors consider it likely that the guarantee will crystallise.
The Group's exposure to market price risk comprises mainly
movements in the value of the Group's investments. It should be
noted that the prices of options tend to be more volatile than the
prices of the underlying securities. The Joint Managers assess the
exposure to market risk when making each investment decision
and monitor the overall level of market risk on the whole of the
investment portfolio on an ongoing basis.

interim management report (continued)

The functional and presentational currency of the Group is Sterling,
and therefore, the Group's principal exposure to foreign currency
risk comprises investments priced in other currencies, principally
US Dollars.
The Group invests in equities and other investments that are readily
realisable.
related party
transactions
These are listed in note 10 to the half yearly condensed financial
statements on page 18.
CULS On 22 March 2013, a final conversion notice was posted to all holders
of the Convertible Unsecured Loan Stock 2013 ("CULS") reminding
them that the final conversion date of the Stock was on 30
April
2013. The holders of 1,396,825 CULS elected to convert their stock
on 30 April 2013. The remaining 158,102 units were converted at the
discretion of the Trustee, The Law Debenture Trust Corporation p.l.c.,
on 16
May 2013, pursuant to the Trust Deed constituting the Stock
dated 26
November 1993 (as amended and supplemented). Following
these actions, there are no longer any units of CULS in issue.
By Order of the Board
The Hon. Peregrine Moncreiffe
Chairman
17 September 2013

responsibility statement

The Directors confirm to the best of their knowledge that:

  • The condensed set of financial statements contained within this half yearly financial report have been prepared in accordance with International Accounting Standard 34 'Interim Financial Reporting' as adopted by the European Union and gives a true and fair view of the assets, liabilities, financial position and profit of the Group; and
  • The half yearly financial report includes a fair review of the information required by the FCA's Disclosure and Transparency Rule 4.2.7R being disclosure of important events that have occurred during the first six months of the financial year, their impact on the condensed set of financial statements and a description of the principal risks and uncertainties for the remaining six months of the year; and
  • The half yearly financial report includes a fair review of the information required by the FCA's Disclosure and Transparency Rule 4.2.8R being disclosure of related party transactions during the first six months of the financial year, how they have materially affected the financial position of the Company during the period and any changes therein.

The half yearly financial report was approved by the Board on 17 September 2013 and the above responsibility statement was signed on its behalf by:

The Hon. Peregrine Moncreiffe Chairman

17 September 2013

condensed consolidated statement of comprehensive income

Six months ended Six months ended
31 July
2013
(unaudited)
31 July
2012
(unaudited)
Revenue
£'000
Capital
£'000
Total
£'000
Revenue
£'000
Capital
£'000
Total
£'000
Income
Net gains on investments at
2,961 2,961 2,689 2,689
fair value
Net losses on investment property

21,780
(141)
21,780
(141)

3,584
3,584
Currency exchange gains/(losses) 5 415 420 (195) (195)
total income 2,966 22,054 25,020 2,689 3,389 6,078
Expenses
Investment management
fee (note 2) (1,337) (1,337) (1,108) (1,108)
Other expenses
Share based remuneration
(1,074)
(180)

(1,074)
(180)
(1,221)
(173)

(1,221)
(173)
Share of net return of associate 2,061 2,061 994 994
return before finance costs
and taxation
375 24,115 24,490 187 4,383 4,570
Finance costs (419) (419) (494) (494)
return before taxation (44) 24,115 24,071 (307) 4,383 4,076
Taxation
return for the period (44) 24,115 24,071 (307) 4,383 4,076
return attribution to:
Equity holders of the Company
Non-controlling interest
(171)
127
24,160
(45)
23,989
82
(428)
121
4,383
3,955
121
(44) 24,115 24,071 (307) 4,383 4,076
earnings per ordinary share (note 4)
Basic
Diluted
158.4p
150.7p
27.9p
24.9p

The total column of the statement is the Statement of Comprehensive Income of the Group prepared in accordance with IFRS. The supplementary revenue and capital columns are presented for information purposes as recommended by the Statement of Recommended Practice issued by the Association of Investment Companies.

All items in the above Statement derive from continuing operations. No operations were acquired or discontinued in the period.

condensed consolidated statement of comprehensive income (continued)

Year ended
31 January
2013
(audited)
Total
£'000
Capital
£'000
Revenue
£'000
Income
Net gains on investments at
5,474 5,474
fair value 43,682 43,682
Net losses on investment property (1,507) (1,507)
Currency exchange gains/(losses) (237) (237)
total income 47,412 41,938 5,474
Expenses
Investment management
fee (note 2) (3,633) (1,417) (2,216)
Other expenses (2,028) (2,028)
Share based remuneration (355) (355)
Share of net return of associate 5,259 5,259
return before finance costs
and taxation
46,655 45,780 875
Finance costs (951) (951)
return before taxation 45,704 45,780 (76)
Taxation (192) (192)
return for the year 45,512 45,780 (268)
return attribution to:
Equity holders of the Company
Non-controlling interest
45,767
(255)
46,261
(481)
(494)
226
45,512 45,780 (268)
earnings per ordinary share (note 4)
Basic
Diluted
321.0p
284.4p

All of the total comprehensive (loss)/income for the period is attributable to the owners of the Group.

The total column of the statement is the Statement of Comprehensive Income of the Group prepared in accordance with IFRS. The supplementary revenue and capital columns are presented for information purposes as recommended by the Statement of Recommended Practice issued by the Association of Investment Companies.

All items in the above Statement derive from continuing operations. No operations were acquired or discontinued in the period.

condensed consolidated statement of changes in equity

Share Share
Share CULS options premium Capital
capital reserve reserve account reserve
£'000 £'000 £'000 £'000 £'000
six months ended 31 July 2013
(unaudited)
31 January 2013 718 12 775 1,301 268,141
Total comprehensive income for the period 24,160
Shares purchased for cancellation (22)
Arising on conversion of CULS 78 (12)
Share options expenses 180
31 July 2013 796 955 1,301 292,279
six months ended 31 July 2012
(unaudited)
31 January 2012 706 14 420 1,301 221,880
Total comprehensive income for the period 4,383
Arising on conversion of CULS 12 (2)
Share options expenses 173
31 July 2012 718 12 593 1,301 226,263
year ended 31 January 2013
(audited)
31 January 2012 706 14 420 1,301 221,880
Total comprehensive income for the year 46,261
Arising on conversion of CULS 12 (2)
Share option expenses 355
31 January 2013 718 12 775 1,301 268,141

condensed consolidated statement of changes in equity (continued)

Total
£'000
controlling Revenue redemption
interest
£'000
reserve
£'000
reserve
£'000
six months ended 31 July 2013
(unaudited)
274,421
31 January 2013
6,678 (3,278) 74
24,071
Total comprehensive income for the period
82 (171)

(22)
Shares purchased for cancellation

66
Arising on conversion of CULS

180
Share options expenses
298,716
31 July 2013
6,760 (3,449) 74
six months ended 31 July 2012
(unaudited)
228,544
31 January 2012
6,933 (2,784) 74
4,076
Total comprehensive income for the period
121 (428)

10
Arising on conversion of CULS

173
Share options expenses
232,803
31 July 2012
7,054 (3,212) 74
year ended 31 January 2013
(audited)
228,544
31 January 2012
6,933 (2,784) 74
45,512
Total comprehensive income for the year
(255) (494)

10
Arising on conversion of CULS

355
Share option expenses
274,421 6,678 (3,278) 74

condensed consolidated balance sheet

31 July 31 July 31 January
2013
(audited)
£'000 £'000 £'000
218,997
40,111
25,654
22 36 29
284,791
500 1,076 498
2,685 1,353 2,362
10,319 7,760 9,462
1,170 1,170 1,170
14,674 11,359 13,492
320,041 255,360 298,283
(2,371) (1,045) (2,800)
(66) (66)
(2,371) (1,111) (2,866)
317,670 254,249 295,417
(18,954) (21,446) (20,996)
(18,954) (21,446) (20,996)
(21,325) (22,557) (23,862)
274,421
Investments held by Subsidiary Companies for trading 2013
(unaudited)
240,330
37,300
27,715
305,367
298,716
2012
(unaudited)
180,834
41,742
21,389
244,001
232,803

condensed consolidated balance sheet (continued)

31 July 31 July 31 January
2013 2012 2013
(unaudited) (unaudited) (audited)
£'000 £'000 £'000
represented by:
Share capital 796 718 718
Equity component of CULS 12 12
Share options reserve 955 593 775
Share premium account 1,301 1,301 1,301
Capital reserve 292,279 226,263 268,141
Capital redemption reserve 74 74 74
Revenue reserve (3,449) (3,212) (3,278)
total equity attributable to equity holders
of the Company 291,956 225,749 267,743
Non-controlling interest 6,760 7,054 6,678
total equity attributable to group 298,716 232,803 274,421
net asset value per ordinary share (note 5):
Basic 1,835p 1,572p 1,865p
Diluted 1,824p 1,420p 1,677p

condensed consolidated cash flow statement

Six months Six months Year ended
ended 31 July ended 31 July 31 January
2013 2012 2013
(unaudited) (unaudited) (audited)
Note £'000 £'000 £'000
cash flows from operating activities
Investment income received 1,207 871 1,981
Rental income received 1,366 1,408 2,877
Bank deposit interest received 19 20
Other income 125 353 366
Sale of investments by dealing Subsidiary 742 126
Investment Manager's fees paid (1,975) (1,180) (2,351)
Other cash payments (690) (1,077) (2,482)
cash received from operations
9
775 394 537
Bank interest paid (419) (489) (943)
CULS interest paid (8)
net cash inflow/(outflow) from
operating activities 356 (95) (414)
cash flows from investing activities
Purchases of investments (99,125) (40,238) (75,317)
Sales of investments 101,270 26,476 64,070
net cash inflow/(outflow) from investing activities 2,145 (13,762) (11,247)
cash flows from financing activities
Repayment of fixed term borrowings (2,042) (424) (874)
Repurchase of ordinary shares for cancellation (22)
net cash outflow from financing activities (2,064) (424) (874)
Increase/(decrease) in cash and cash
equivalents for the period 437 (14,281) (12,535)
cash and cash equivalents at the start of
the period 9,462 22,200 22,200
Revaluation of foreign currency balances 420 (159) (203)
cash and cash equivalents at the end of
the period 10,319 7,760 9,462

notes

1. a) general information

North Atlantic Smaller Companies Investment Trust plc ("NASCIT") is a Company incorporated and registered in England and Wales under the Companies Acts 1948 to 1967.

The Company operates as an investment trust company within the meaning of Section 833 of the Companies Act 2006 and has made a successful application under Regulation 5 of the Investment Trust (Approved Company) (Tax) Regulations 2011 for investment trust status to apply to all accounting periods starting on or after 1 February 2012. The Company is managed in such a way to ensure that it continues to meet the eligibility conditions contained in Section 1158 of the Corporation Tax Act 2010 and the ongoing requirements outlined in Chapter 3 of Part 2 of the regulations.

1. b) basis of preparation

The condensed consolidated interim financial statements for the six months ended 31 July 2013 have been prepared in accordance with IAS 34 "Interim Financial Reporting". They do not include all financial information required for full annual financial statements and have been prepared using the accounting policies adopted in the audited financial statements for the year ended 31 January 2013. Those financial statements were prepared in accordance with International Financial Reporting Standards and with the Statement of Recommended Practice ('SORP') for Investment Companies and Venture Capital Trusts issued by the Association of Investment Companies in January 2009.

The condensed consolidated interim financial information includes the financial statements of the Company its wholly owned Subsidiary, Consolidated Venture Finance Limited and its 68.1% ownership of Hampton Investment Properties Limited, for the six months ended 31 July 2013.

1. c) going concern

The Company has adequate financial resources and no significant investment commitments and as a consequence, the Directors believe that the Company is well placed to manage its business risks successfully. After making appropriate enquiries, the Directors have a reasonable expectation that the Company has adequate available financial resources to continue in operational existence for the foreseeable future and accordingly have concluded that it is appropriate to continue to adopt the going concern basis in preparing this half yearly financial report.

2. investment management and performance fees

A Performance Fee is only payable if the investment portfolio outperforms the Sterling adjusted Standard & Poor's 500 Composite Index at the end of each financial year and is limited to a maximum payment of 0.5% of Shareholders' Funds.

In accordance with the Statement of Recommended Practice ("SORP") for investment trust companies, an amount is included in these financial statements for the Performance Fee that could be payable based on investment performance to 31 July 2013.

At that date, no Performance Fee has been accrued for in the accounts (31 July 2012: £nil; 31 January 2013: £1,344,000 plus VAT) and is allocated 100% to capital.

3. taxation

The Company has an effective tax rate of 0%. The estimated effective tax rate is 0% as investment gains are exempt from tax owing to the Company's status as an Investment Trust and there is expected to be an excess of management expenses over taxable income and thus there is no charge for corporation tax.

4. earnings per ordinary share
Revenue Capital
*Net Per *Net Per
return Ordinary Share return Ordinary Share
£'000 Shares pence £'000 Shares pence
six months ended 31 July 2013
(unaudited)
Basic return (171) 15,143,692 (1.1) 24,160 15,143,692 159.5
CULS** 769,963 769,963
Diluted return (171) 15,913,655 (1.1) 24,160 15,913,655 151.8
six months ended 31 July 2012
(unaudited)
Basic return (428) 14,156,727 (3.0) 4,383 14,156,727 31.0
CULS*** 8 1,756,325 1,756,325
Diluted return (420) 15,913,052 (2.6) 4,383 15,913,052 27.5
year ended 31 January 2013
(audited)
Basic return (494) 14,258,470 (3.5) 46,261 14,258,470 324.5
CULS*** 8 1,834,771 1,834,771
Diluted return (486) 16,093,241 (3.0) 46,261 16,093,241 287.5

Basic return per Ordinary Share has been calculated using the weighted average number of Ordinary Shares in issue during the period.

  • * Net return on ordinary activities attributable to Ordinary Shareholders.
  • ** All of the remaining CULS were converted during the period to 31 July 2013. The weighted average of the CULS that could have been issued relate only to the part of the period prior to their conversion.
  • *** CULS interest cost and excess of the total number of potential shares on CULS conversion over the number that could have been issued at the average market price from the conversion proceeds, as calculated in accordance with IAS 33: Earnings per share.
Total
*Net Per
return Ordinary Share
£'000 Shares pence
six months ended 31 July 2013
(unaudited)
23,989 15,143,692 158.4 Basic return
769,963 CULS**
23,989 15,913,655 150.7 Diluted return
six months ended 31 July 2012
(unaudited)
3,955 14,156,727 27.9 Basic return
8 1,756,525 CULS***
3,963 15,913,052 24.9 Diluted return
year ended 31 January 2013
(audited)
45,767 14,258,470 321.0 Basic return
8 1,834,771 CULS***
45,775 16,093,241 284.4 Diluted return

Basic return per Ordinary Share has been calculated using the weighted average number of Ordinary Shares in issue during the period.

  • * Net return on ordinary activities attributable to Ordinary Shareholders.
  • ** All of the remaining CULS were converted during the period to 31 July 2013. The weighted average of the CULS that could have been issued relate only to the part of the period prior to their conversion.
  • *** CULS interest cost and excess of the total number of potential shares on CULS conversion (applicable prior to conversion) over the number that could have been issued at the average market price from the conversion proceeds, as calculated in accordance with IAS 33: Earnings per share.

5. net asset value per ordinary share and share capital

The basic net asset value per Ordinary Share is based on net assets of £291,956,000 (31 July 2012: £225,749,000; 31 January 2013: £267,743,000) and on 15,912,434 Ordinary Shares (31 July 2012: 14,359,107; 31 January 2013: 14,359,107) being the number of Ordinary Shares in issue at the period end.

The diluted net asset value per Ordinary Share is calculated on the assumption that all 460,000 (31 July 2012: 460,000; 31 January 2013: 460,000) Share Options in-the-money were exercised at the prevailing exercise prices, giving a total of 16,372,434 issued Ordinary Shares (31 July 2012: 16,373,052; 31 January 2013: 16,374,034). For 31 July 2012 and 31 January 2013 the dilution would also have included the fact that any 2013 CULS had been fully converted at par.

During the year, 1,600 Ordinary Shares were bought back for cancellation at a cost of £22,000.

6. debenture loan – Convertible Unsecured Loan Stock ('CULS') 2013

The final conversion opportunity for the CULS units was on 30 April 2013. The CULS were convertible into Ordinary shares of 5p each at a rate of one 5p Ordinary share for every unit of 5p.

The final conversion notice was posted to loan stock holders on 22 March 2013 reminding them of their conversion rights and advising of the procedure if they chose not to convert. Holders of 1,396,825 CULS opted to convert. These were converted on 30 April 2013. The remaining 158,102 CULS were converted by the Trustee on 28 May 2013. At 31 July 2013, no CULS remain in issue.

7. share based remuneration

As at 31 July 2013 and as at the date of this report, there were a total of 460,000 options in issue with an estimated fair value of £1.1m. (31 July 2012: 460,000; 31 January 2013: 460,000). 430,000 options of which are under the 2011 options scheme and 30,000 options are under the 2012 option scheme.

8. bank loans

Hampton Investment Properties Limited has a five year facility with RBS which commenced on 2 February 2011 and is secured over the investment property. The loan bears interest at the rate of LIBOR plus 2.76%. During the period Hampton Investment Properties Limited made five repayments totalling £2,042,000, leaving a balance outstanding of £18,954,000.

9. reconciliation of total return from ordinary activities before finance costs and
taxation to cash received from operations
Six months Six months Year ended
ended 31 July ended 31 July 31 January
2013 2012 2013
(unaudited) (unaudited) (audited)
£'000 £'000 £'000
Total return from ordinary activities before
finance costs and taxation* 24,490 4,570 46,655
Gains on investments (22,054) (3,389) (41,938)
Share of net return of associate (2,061) (994) (5,259)
Share based remuneration 180 173 355
Depreciation 7 (5) 12
Dividends and interest reinvested (53) (117)
Decrease/(increase) in debtors and accrued income 148 98 (723)
Changes relating to investments of dealing Subsidiary 493 17 16
(Decrease)/increase in creditors and accruals (428) (23) 1,536
cash received from operations 775 394 537

* Including share of net return of associate.

10. related party transactions

There have been no changes to the related party arrangements or transactions as reported in the Statutory Annual Financial Report for the year ended 31 January 2013.

The Joint Manager, Harwood Capital LLP, is regarded as a related party of the Company. The amounts payable to the Joint Manager and Growth Financial Services Limited ("GFS") in respect of investment management for the six months to 31 July 2013 are as follows:

Six months Six months Year ended
ended 31 July ended 31 July 31 January
2013 2012 2013
(unaudited) (unaudited) (audited)
£'000 £'000 £'000
Annual fee 1,337 1,108 2,216
Performance fee 1,344
Irrecoverable VAT thereon 73
1,337 1,108 3,633

In addition to the management fees disclosed above, Harwood Capital LLP is also paid an investment management related fee of £125,000 per annum.

Shareholders should also note the payments made under share based remuneration as disclosed in note 7 to these financial statements.

11. financial information

The annual financial information contained in this half yearly report does not constitute full Statutory accounts as defined in Section 434 of the Companies Act 2006. The financial information for the periods ended 31 July 2013 and 31 July 2012 is not a financial year and has not been audited. The statutory accounts for the financial year ended 31 January 2013 have been delivered to the Registrar of Companies.

shareholder information

financial calendar Preliminary results
Annual Report
Annual General Meeting
Half yearly figures announced
Half yearly Report posted
May
May
June
September
September
share price The Company's mid-market share price is quoted daily in the
Financial Times appearing under "Investment Companies".
It also appears on:
Bloomberg:
SEAQ Ordinary Shares:
Trustnet:
NAS. LN
NAS
www.trustnet.ltd.uk
net asset value Harwood
Capital LLP website:
www.harwoodcapital.co.uk
The latest net asset value of the Company can be found on the
share dealing Investors wishing to purchase more Ordinary Shares or dispose of
all or part of their holding may do so through a stockbroker. Many
banks also offer this service.
The Company's registrars are Capita Registrars. In the event of any
queries regarding your holding of shares, please contact the registrars
on: 0871 664 0384, or by email on [email protected]
Changes of name or address must be notified to the registrars in
writing at:
Capita Registrars
The Registry
34 Beckenham Road
Beckenham
Kent BR3 4TU

shareholder information (continued)

Directors The Hon. P D E M Moncreiffe (Chairman) C H B Mills (Chief Executive) K Siem C L A Irby E F Gittes

Joint Manager

Harwood Capital LLP (Authorised and regulated by the Financial Conduct Authority) 6 Stratton Street Mayfair London W1J 8LD Telephone: 020 7640 3203

Financial Adviser and Stockbroker

Winterflood Investment Trusts The Atrium Building Cannon Bridge 25 Dowgate Hill London EC4R 2GA

Company Secretary and Registered Office

Bonita Guntrip ACIS 6 Stratton Street Mayfair London W1J 8LD Telephone: 020 7640 3203

Registrars

Capita Registrars 34 Beckenham Road Beckenham Kent BR3 4TU

Auditors

KPMG Audit p.l.c. 15 Canada Square London E14 5GL

Cover Image: 'HMS Brunswick breaking the line at the battle of the "Glorious First of June" 1794' Artist: Nicholas Pocock (© National Maritime Museum, Greenwich, London)

Talk to a Data Expert

Have a question? We'll get back to you promptly.